(E)-2-(1-(4-methoxyphenyl)prop-1-en-2-yl)benzo[d]thiazole

ID: ALA4866707

PubChem CID: 12382489

Max Phase: Preclinical

Molecular Formula: C17H15NOS

Molecular Weight: 281.38

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(/C=C(\C)c2nc3ccccc3s2)cc1

Standard InChI:  InChI=1S/C17H15NOS/c1-12(11-13-7-9-14(19-2)10-8-13)17-18-15-5-3-4-6-16(15)20-17/h3-11H,1-2H3/b12-11+

Standard InChI Key:  OIEOQSATNCLVJB-VAWYXSNFSA-N

Molfile:  

 
     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
   18.1089  -16.4346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1077  -17.2541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8158  -17.6631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8140  -16.0257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5226  -16.4310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5229  -17.2496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3015  -17.5024    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   20.7825  -16.8399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3011  -16.1778    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5997  -16.8396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0086  -17.5472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0081  -16.1317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8253  -16.1314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2297  -16.8402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0461  -16.8403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4553  -16.1319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0420  -15.4220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2270  -15.4254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2725  -16.1305    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.6823  -16.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  1  0
M  END

Associated Targets(Human)

GLO1 Tchem Glyoxalase I (402 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 281.38Molecular Weight (Monoisotopic): 281.0874AlogP: 4.87#Rotatable Bonds: 3
Polar Surface Area: 22.12Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.05CX LogP: 4.97CX LogD: 4.97
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.68Np Likeness Score: -1.13

References

1. Azuma M, Inoue M, Nishida A, Akahane H, Kitajima M, Natani S, Chimori R, Yoshimori A, Mano Y, Uchiro H, Tanuma SI, Takasawa R..  (2021)  Addition of hydrophobic side chains improve the apoptosis inducibility of the human glyoxalase I inhibitor, TLSC702.,  40  [PMID:33711442] [10.1016/j.bmcl.2021.127918]

Source